Prometheus Biosciences Completes Enrollment of the ARTEMIS-UC Cohort 1 Phase 2 Study in Ulcerative Colitis
- Global Phase 2 placebo-controlled trial enrolled twice as fast as the industry average, establishing a roadmap for future studies -...
- Global Phase 2 placebo-controlled trial enrolled twice as fast as the industry average, establishing a roadmap for future studies -...
Announces Completion of More than 80 Successful Cloud ERP Migrations to Date LOUISVILLE, Colo., July 14, 2022 /PRNewswire/ -- Global Healthcare...
SANTA CRUZ, Calif., July 14, 2022 /PRNewswire/ -- Fullpower®-AI, the leading IoT biosensing and sleep technology company, today announced that...
MELBOURNE, Australia, July 14, 2022 /PRNewswire/ -- A Qualitative Research Study accomplished by Data Bridge Market research's database of 350...
Recognized in the Wearable Category for the first-of-its-kind smart sensor platform for respiratory health, RESP® PHILADELPHIA, July 14, 2022 /PRNewswire/...
Quantitative biomarkers of demyelination can improve clinical trial design and accelerate development of disease-modifying therapeutics SAN FRANCISCO, July 14, 2022...
Powered by a database of over 10,000 surgical cases, Medtronic continues to evolve the UNiD™ platform to help surgeons plan...
DURBAN, South Africa, July 14, 2022 /PRNewswire/ -- "Global Life Science Software Market" the new research report adds in Data Bridge...
SOUTH SAN FRANCISCO, Calif., July 14, 2022 (GLOBE NEWSWIRE) -- Frontier Medicines Corporation, a precision medicine company seeking to unlock...
Many people are seeking pathways to financial freedom. One of the most common strategies is to create a “side hustle”...
By Shannon Burke, Senior Vice President and General Manager of Health Systems, Synchrony Health & Wellness Health systems are facing...